Your browser doesn't support javascript.
loading
[Multicenter phase II clinical trial of arsenic trioxide injection in the treatment of primary hepatocarcinoma].
Qu, Feng-lian; Hao, Xue-zhi; Qin, Shu-kui; Liu, Ji-wei; Sui, Guang-jie; Chen, Qiang; Qu, Tao; Zhang, He-ping; Sun, Yan.
Affiliation
  • Qu FL; Department of Medical Oncology, Chinese Academy of Medical Sciences, Beijing, China.
Zhonghua Zhong Liu Za Zhi ; 33(9): 697-701, 2011 Sep.
Article in Zh | MEDLINE | ID: mdl-22340053
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Oxides / Arsenicals / Carcinoma, Hepatocellular / Liver Neoplasms / Antineoplastic Agents Type of study: Clinical_trials / Observational_studies / Prognostic_studies Aspects: Patient_preference Language: Zh Journal: Zhonghua Zhong Liu Za Zhi Year: 2011 Document type: Article Affiliation country: China
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Oxides / Arsenicals / Carcinoma, Hepatocellular / Liver Neoplasms / Antineoplastic Agents Type of study: Clinical_trials / Observational_studies / Prognostic_studies Aspects: Patient_preference Language: Zh Journal: Zhonghua Zhong Liu Za Zhi Year: 2011 Document type: Article Affiliation country: China